New drug duo tested for Tough-to-Treat blood cancer
NCT ID NCT06988488
Summary
This study is testing a new combination of two drugs, mezigdomide and elranatamab, for people with multiple myeloma that has come back or stopped responding to previous treatments. The main goals are to find the safest and most effective dose and to see how well the combination works at controlling the cancer. It is for adults who have already tried 1 to 4 prior lines of therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Alexandra General Hospital of Athens
RECRUITINGAthens, Attikí, 115 28, Greece
Contact Phone: •••-•••-••••
-
Arthur J E Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
Contact Phone: •••-•••-••••
-
Evangelismos General Hospital of Athens
RECRUITINGAthens, Attikí, 106 76, Greece
Contact Phone: •••-•••-••••
-
Hackensack University Medical Center
RECRUITINGHackensack, New Jersey, 07601, United States
Contact Phone: •••-•••-••••
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
Contact Phone: •••-•••-••••
-
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
Contact Phone: •••-•••-••••
-
Local Institution - 0026
NOT_YET_RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact
-
Local Institution - 0027
NOT_YET_RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
Contact
-
Local Institution - 0030
NOT_YET_RECRUITINGSuzhou, Jiangsu, 215006, China
Contact
-
Local Institution - 0031
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200434, China
Contact
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-••••
-
Royal Marsden Hospital (Sutton)
RECRUITINGLondon, Sutton, SM2 5PT, United Kingdom
Contact Phone: •••-•••-••••
-
St. Olavs Hospital
RECRUITINGTrondheim, Sør-Trøndelag, 7030, Norway
Contact Phone: •••-•••-••••
-
Sykehusapoteket Ull
RECRUITINGOslo, 0450, Norway
Contact Phone: •••-•••-••••
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
Contact Phone: •••-•••-••••
-
Universitaetsklinikum Carl Gustav Carus Dresden
RECRUITINGDresden, 01307, Germany
Contact Phone: •••-•••-••••
-
Universitaetsklinikum Hamburg-Eppendorf
RECRUITINGHamburg, 20246, Germany
Contact Phone: •••-•••-••••
-
Universitaetsklinikum Heidelberg
RECRUITINGHeidelberg, 69120, Germany
Contact Phone: •••-•••-••••
-
University College London Hospital
RECRUITINGLondon, England, W1T 7HA, United Kingdom
Contact Phone: •••-•••-••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294-3300, United States
Contact Phone: •••-•••-••••
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
-
Yale New Haven Hospital-Smilow Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.